Fig. 6 | Scientific Data

Fig. 6

From: Identifying immune checkpoint-related lncRNA biomarkers for immunotherapy response and prognosis in cancers

Fig. 6The alternative text for this image may have been generated using AI.

ICPaLncCRPs have an effect on the prognosis of cancer patients. (a) The radar chart shows numbers of survival-associated ICPaLncCRPs across cancer types. (b) The bar plot shows numbers of survival-associated ICPaLncCRPs related to one, two and three kinds of cancer types. (c) The heatmap shows P values of survival-associated ICPaLncCRPs in three cancer types. (d) The forest plot shows that the signature (ICPaLncCRPs: IDO1-MIR155HG) is independent from other risk factors for prognostic prediction. Nomogram to estimate the prognostic risk of IDO1 and MIR155HG pair. Each variable axis, containing age and corresponded to the characteristic attribute score of single sample. The likelihood of 3- and 5 years OS is determined on the survival axis. (e) Kaplan-Meier survival analysis of the OS for patients with high (blue) and low (yellow) risk scores. (f) The calibration curves yield an accurate predictive capability that was extremely close to actual survival (3- and 5 years OS) are presented by the calibration plots. X-axis represents the predicted value of survival probability and y-axis represents actual survival possibility.

Back to article page